Laboratory Gap Analysis across high risk...
Transcript of Laboratory Gap Analysis across high risk...
![Page 1: Laboratory Gap Analysis across high risk regionsregist2.virology-education.com/presentations/2019/2ICREID/32_Demanou.pdf · Strong surveillance and LABORATORY CAPACITY is crucial](https://reader031.fdocuments.net/reader031/viewer/2022011810/5d642d1188c993f61b8b5c51/html5/thumbnails/1.jpg)
Laboratory Gap Analysis across high
risk regions
Dr Maurice DemanouHead of Arbovirus Laboratory
(WHO Yellow Fever Reference Laboratory)CENTRE PASTEUR CAMEROON
Email. [email protected]…………………
Lunch Symposium: Challenges in EID preparedness, the Yellow fever caseThe 2nd International Conference on (Re-)emerging Infectious Diseases
Addis Ababa, Ethiopia - March 13-15, 2019
![Page 2: Laboratory Gap Analysis across high risk regionsregist2.virology-education.com/presentations/2019/2ICREID/32_Demanou.pdf · Strong surveillance and LABORATORY CAPACITY is crucial](https://reader031.fdocuments.net/reader031/viewer/2022011810/5d642d1188c993f61b8b5c51/html5/thumbnails/2.jpg)
DISCLOSURE
The Author has
nothing to disclose
![Page 3: Laboratory Gap Analysis across high risk regionsregist2.virology-education.com/presentations/2019/2ICREID/32_Demanou.pdf · Strong surveillance and LABORATORY CAPACITY is crucial](https://reader031.fdocuments.net/reader031/viewer/2022011810/5d642d1188c993f61b8b5c51/html5/thumbnails/3.jpg)
OUTLINE
• AFRO Lab Network
• GAVI/WHO Assessments
• Gaps
• Way forward
![Page 4: Laboratory Gap Analysis across high risk regionsregist2.virology-education.com/presentations/2019/2ICREID/32_Demanou.pdf · Strong surveillance and LABORATORY CAPACITY is crucial](https://reader031.fdocuments.net/reader031/viewer/2022011810/5d642d1188c993f61b8b5c51/html5/thumbnails/4.jpg)
Strong surveillance and LABORATORY CAPACITY is crucial
4
•Vaccine supply limitation, one of the primary pillars of the EYE
Strategy is to prioritize public health interventions based on risks.
High risk (27 countries)
Moderate risk (8 countries)
Potential for transmission (8 countries + 4 without data)
• Current limitations in YF diagnosis capacity,
particularly in Africa, A STRONG LABORATORY
NETWORK is crucial to ensure rapid and reliable
case confirmation and outbreak characterization.
![Page 5: Laboratory Gap Analysis across high risk regionsregist2.virology-education.com/presentations/2019/2ICREID/32_Demanou.pdf · Strong surveillance and LABORATORY CAPACITY is crucial](https://reader031.fdocuments.net/reader031/viewer/2022011810/5d642d1188c993f61b8b5c51/html5/thumbnails/5.jpg)
AFRO Yellow Fever Laboratory Network
Ten years later…
YF laboratory network has been crucial in confirming multiple outbreaks during this time
![Page 6: Laboratory Gap Analysis across high risk regionsregist2.virology-education.com/presentations/2019/2ICREID/32_Demanou.pdf · Strong surveillance and LABORATORY CAPACITY is crucial](https://reader031.fdocuments.net/reader031/viewer/2022011810/5d642d1188c993f61b8b5c51/html5/thumbnails/6.jpg)
Country Name of Laboratory City
Angola INSP Luanda
Benin Institut National de Santé Publique Cotonou
Burkina Faso Centre Muraz Bobo Dioulasso
Cameroon Centre Pasteur Cameroon Yaounde
CAR Institute Pasteur Bangui
Chad LABOHGRN N'Djamena
DRC National Institute for Biomedical Research (INRB) Kinshasha
Republic of Congo None (Refers to Kinshasha)
Cote d'Ivoire Institut Pasteur de Côte d'Ivoire Abidjan
Ethiopia Ethiopian Public Health Institute /EPHI, Virology and Rickettsiology Unit Addis Ababa
The Gambia National Health Laboratory Services, Royal Victoria Teaching Hospital Banjul
Ghana National Public Health and Reference Laboratory Accra
Guinea Centre Hospitalier Universitaire Donka, Projet des Fièvres Hémorragiques en Guinée Conakry
Guinea-Bissau Laboratoire National de Sante publique Bissau
Kenya Center for Virus Research, Kenya Medical Research Institute (KEMRI) Nairobi
Liberia National reference laboratory, Liberia Institute for Biomedical Research campus Charlesville, Margibi Couty
Mali Institut National de Santé Publique Bamako
Niger Niamey National Hospital Niamey
Nigeria 1. Yusuf Dantsoho Memorial Hospital Kaduna
1. Maitama District Hospital FCT/Abuja
1. Gombe Specialist Hospital Gombe
1. Central Public Health Laboratory Lagos
Senegal Institut Pasteur de Dakar Dakar
Sierra Leone National Public Health Laboratory Lakka
South Sudan None
Sudan National Public Health Laboratory Khartoum
Togo Laboratoire de Sérologie, Institut National d’Hygiène Lomé
Uganda Uganda Virus Research Institute Entebbe
Laboratories in Global Yellow Fever Laboratory Networkin Gavi-Eligible Countries at High Risk for Yellow Fever
![Page 7: Laboratory Gap Analysis across high risk regionsregist2.virology-education.com/presentations/2019/2ICREID/32_Demanou.pdf · Strong surveillance and LABORATORY CAPACITY is crucial](https://reader031.fdocuments.net/reader031/viewer/2022011810/5d642d1188c993f61b8b5c51/html5/thumbnails/7.jpg)
SEVERAL GAPS RECORDED FOLLOWING
THE GAVI LABORATORY ASSESSMENTS
IN HIGH RISK AND GAVI ELIGIBLE COUNTRIES
![Page 8: Laboratory Gap Analysis across high risk regionsregist2.virology-education.com/presentations/2019/2ICREID/32_Demanou.pdf · Strong surveillance and LABORATORY CAPACITY is crucial](https://reader031.fdocuments.net/reader031/viewer/2022011810/5d642d1188c993f61b8b5c51/html5/thumbnails/8.jpg)
No budget for YF laboratory
None of the laboratories assessed had a YF activity specific budget…
Reagent procurement
Shortages or Stock outs of critical reagents constitute a major cause of
testing interruptions or delays (20% of the samples were not tested at all
in National labs in 2017)
Sample shipments
Delays in reporting of confirmed case due to:
- Lack of funding for timely shipment of samples to RRL for confirmation
- Absence of collaboration of certain courier services
Funding, Procurement, Shipments
![Page 9: Laboratory Gap Analysis across high risk regionsregist2.virology-education.com/presentations/2019/2ICREID/32_Demanou.pdf · Strong surveillance and LABORATORY CAPACITY is crucial](https://reader031.fdocuments.net/reader031/viewer/2022011810/5d642d1188c993f61b8b5c51/html5/thumbnails/9.jpg)
Sample testing
- Use of “In-house” serologic tests (MAC ELISA) with
non commercial reagents provided by different
laboratories (IPD, CDC, CPC, etc.)
- Multiple testing protocols within the network
- 92% of laboratories do molecular testing for other
pathogens, but <50% do such testing for yellow fever
- Lack of common molecular testing protocol or platform
Sample processing
![Page 10: Laboratory Gap Analysis across high risk regionsregist2.virology-education.com/presentations/2019/2ICREID/32_Demanou.pdf · Strong surveillance and LABORATORY CAPACITY is crucial](https://reader031.fdocuments.net/reader031/viewer/2022011810/5d642d1188c993f61b8b5c51/html5/thumbnails/10.jpg)
- Laboratories often understaffed with multiple testing
responsibilities, so YF often relatively low priority
- Lack of training with current protocols at some laboratories
- Difficulties in monitoring IHC (No Levey Jennings graph, etc.)
- No routine or formal program for YF serologic or molecular
proficiency testing
- Infrequent accreditation visits
Staff, training & QA/QC
![Page 11: Laboratory Gap Analysis across high risk regionsregist2.virology-education.com/presentations/2019/2ICREID/32_Demanou.pdf · Strong surveillance and LABORATORY CAPACITY is crucial](https://reader031.fdocuments.net/reader031/viewer/2022011810/5d642d1188c993f61b8b5c51/html5/thumbnails/11.jpg)
Equipment and facilities
Equipment and Facilities
- Lack of biosafety cabinets for sample processing
- Difficulties in repairing and maintaining equipment (No
regular preventive maintenance)
- Difficulties to calibrate instruments
- Laboratory space inadequate or shared across multiple
activities
- Electricity disruptions
![Page 12: Laboratory Gap Analysis across high risk regionsregist2.virology-education.com/presentations/2019/2ICREID/32_Demanou.pdf · Strong surveillance and LABORATORY CAPACITY is crucial](https://reader031.fdocuments.net/reader031/viewer/2022011810/5d642d1188c993f61b8b5c51/html5/thumbnails/12.jpg)
Some of these gaps are currently been addressed:
- Funding from GAVI (8.2 million USD) to strengthen
laboratory capacity in high risk and GAVI eligible countries
- CDC has developed a MAC ELISA kit for YF which is under
validation, which should help address reagent logistic problems
- Regional YF diagnostic training workshop have or are been
organized: Uganda (2017), Cameroon (July 2019) and
Senegal (July-August 2019)
Way forward…(1/2)
![Page 13: Laboratory Gap Analysis across high risk regionsregist2.virology-education.com/presentations/2019/2ICREID/32_Demanou.pdf · Strong surveillance and LABORATORY CAPACITY is crucial](https://reader031.fdocuments.net/reader031/viewer/2022011810/5d642d1188c993f61b8b5c51/html5/thumbnails/13.jpg)
Some of these gaps are currently been addressed:
- Already two RRLs for YF in Africa now (IPD and UVRI) and
one potential under consideration (CPC)
- Laboratory Technical Working Group (LTWG) is currently
working to address a common algorithm in the AFRO YF
Lab Network and allow case confirmation at national level
- CPC received 3 request from National labs for QA/QC
training (CAR, CHAD and DRC)
Way forward (2/2)
![Page 14: Laboratory Gap Analysis across high risk regionsregist2.virology-education.com/presentations/2019/2ICREID/32_Demanou.pdf · Strong surveillance and LABORATORY CAPACITY is crucial](https://reader031.fdocuments.net/reader031/viewer/2022011810/5d642d1188c993f61b8b5c51/html5/thumbnails/14.jpg)
The end…
THANK YOU
Acknowledgement
Barbara W. Johnson
Gamou Fall
Jean-Luc Betoulle
Lee Hampton (GAVI)
Mick N. Mulders (WHO, HQ)